Methotrexate plus reduced or full-dose glucocorticoids for the treatment of active, moderate-to-severe Graves' orbitopathy

Shen, LY; Ye, L; Zhu, W; Jiao, Q; Zhou, YL; Wang, S; Wang, WQ; Ning, G

Wang, S; Wang, WQ (通讯作者),Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai Inst Endocrine & Metab Dis, Sch Med,Dept Endocrine & Metab Dis, Shanghai, Peoples R China.;Wang, S; Wang, WQ (通讯作者),Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Shanghai Natl Clin Res Ctr Metab Dis,Key Lab Endoc, Shanghai, Peoples R China.

EUROPEAN THYROID JOURNAL, 2022; 11 (5):

Abstract

Objective: A combination of glucocorticoids with mycophenolate is recommended by current guidelines to boost response to Graves' orbitopathy (GO) ther......

Full Text Link